Sphingosine I Phosphate (S1P) Increased IL-6 Expression and Cell Growth in Endometriotic Cells

Objects: There is growing evidence that sphingosine 1-phosphate (S1P) is involved in inflammatory diseases. As endometriosis is known as an inflammatory disease, we investigated the role of S1P system in the development of endometriosis. Methods: The expression of sphingosine kinase (SphK) 1 in endometriosis lesions was examined by immunohistochemistry. The cystic fluid of ovarian cysts/tumors were obtained to measure S1P concentrations. Endometriotic stromal cells (ESC) derived from endometrioma were used for in vitro experiments. Results: Sphingosine kinase 1 was detected in epithelium and stromal cells of endometriotic lesions. The mean S1P concentration in the cystic fluid of endometriomas was higher than that in nonendometriomas significantly (98.2 nM vs less than 1.5 nM, P <.01). Interleukin-1β (IL-1β) or transforming growth factor-β exhibited 2.7-fold and 11.5-fold increase in SphK1 messenger RNA (mRNA) expression in ESC, respectively (P <.01). Higher dose of S1P (125nM) increased the cell number of ESC by 20%, and low dose of S1P (1.25 nM and 12.5 nM) induced IL-6 mRNA production and IL-6 secretion by ESC dose-dependently. JTE013, an antagonist for S1PR2, partially suppressed IL-6 induction by S1P (P <.05). JTE013 and VPC23019, an antagonist for S1PR1 and S1PR3, suppressed the ESC proliferation induced by S1P. Conclusion: The present study for the first time proved that the SphK-S1P-S1PR axis play a role of accelerating inflammation and growth of endometriotic cells. Similar content being viewed by others

Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447): 1789–1799. Scholl B, Bersinger NA, Kuhn A, Mueller MD. Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis. Gynecol Endocrinol. 2009;25(11):701–706. Matorras R, Rodiquez F, Pijoan JI, Ramon O, Gutierrez de Teran G, Rodriguez-Escudero F. Epidemiology of endometriosis in infertile women. Fertil Steril. 1995;63(1):34–38. Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Vigano P. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endo-metriosis. Fertil Steril. 2001;75(1):1–10. Harada T, Iwabe T, Terakawa N. Role of cytokines in endome-triosis. Fertil Steril. 2001;76(1):1–10. Kajihara H, Yamada Y, Kanayama S, et al. New insights into the pathophysiology of endometriosis: from chronic inflammation to danger signal. Gynecol Endocrinol. 2010;27(2):73–79. Gonzalez-Ramos R, van Langendonckt A, Defrere S, et al. Involvement of the nuclear factor-kappaB pathway in the pathogenesis of endometriosis. Fertil Steril. 2010;94(6):1985–1994. Yoshino O, Osuga Y, Hirota Y, et al. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endome-triosis. Am J Reprod Immunol. 2004;52(5):306–311. Yoshino O, Osuga Y, Koga K, et al. FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model. J Reprod Immunol. 2006;72(1–2):85–93. Pyne NJ, Pyne S. Sphingosine 1-phosphate and cancer. Nat Rev Cancer. 2010;10(7):489–503. Spiegel S, Milstien S. The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol. 2011;11(6):403–415. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol. 2010;6(7):489–497. Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012;22(1):50–60. Santulli P, Marcellin L, Noel JC, et al. Sphingosine pathway deregulation in endometriotic tissues. Fertil Steril. 2012;97(4): 904–911. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817–821. Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem. 1993;41(11):1599–1604. Badawy SZ, Cuenca V, Kumar S, Holland J. Effects of chocolate cyst fluid on endometrioma cell growth in culture. Fertil Steril. 1998;70(5):827–830. Taketani Y, Kuo TM, Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol. 1992;167(1):265–270. Capobianco A, Rovere-Querini P. Endometriosis, a disease ofthe macrophage. Front Immunol. 2013;4:9. Liang J, Nagahashi M, Kim EY, et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell. 2013;23(1):107–120. Yamanaka M, Shegogue D, Pei H, et al. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. JBiolChem. 2004;279(52): 53994–54001. Japtok L, Baumer W, Kleuser B. Sphingosine-1-phosphate as signaling molecule in the skin: relevance in atopic dermatitis. AllergoJInt. 2014;23(2):54–59. Watterson KR, Ratz PH, Spiegel S. The role of sphingosine-1-phosphate in smooth muscle contraction. Cell Signal. 2005;17(3): 289–298. Zhang W, An J, Jawadi H, et al. Sphingosine-1-phosphate receptor-2 mediated NFkappaB activation contributes to tumor necrosis factor-alpha induced VCAM-1 and ICAM-1 expression in endothelial cells. Prostaglandins Other Lipid Mediat. 2013;106:62–71. Fan Q, Cheng Y, Chang HM, Deguchi M, Hsueh AJ, Leung PCK. Sphingosine-1-phosphate promotes ovarian cancer cell proliferation by disrupting Hippo signaling. Oncotarget. 2017;8(16): 27166–27176. Akoum A, Lemay A, Paradis I, Rheault N, Maheux R. Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Hum Reprod. 1996;11(10):2269–2275. Witz CA. Interleukin-6: another piece of the endometriosis- cytokine puzzle. Fertil Steril. 2000;73(2):212–214. Velasco I, Rueda J, Acien P. Aromatase expression in endome-triotic tissues and cell cultures ofpatients with endometriosis. Mol Hum Reprod. 2006;12(6):377–381. Sharpe-Timms KL, Nabli H, Zimmer RL, Birt JA, Davis JW. Inflammatory cytokines differentially up-regulate human endo-metrial haptoglobin production in women with endometriosis. Hum Reprod. 2010;25(5):1241–1250. Osuga Y, Hirota Y, Yoshino O, Hirata T, Koga K, Taketani Y. Proteinase-activated receptors in the endometrium and endome-triosis. Front Biosci (Schol Ed). 2012;4:1201–1212. Visentin B, Vekich JA, Sibbald BJ, et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell. 2006;9(3):225–238. Aoki M, Aoki H, Ramanathan R, Hait NC, Takabe K. Sphingosine-1-phosphate signaling in immune cells and inflammation: roles and therapeutic potential. Mediators Inflamm. 2016;2016:8606878. Ebenezer DL, Fu P, Natarajan V. Targeting sphingosine-1-phosphate signaling in lung diseases. Pharmacol Ther. 2016; 168:143–157. Guo L, Ou X, Li H, Han Z. Roles of sphingosine-1-phosphate in reproduction. Reprod Sci. 2014;21(5):550–554. Nakahara T, Iwase A, Nakamura T, et al. Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. Fertil Steril. 2012;98(4):1001–1008 e1001. Skaznik-Wikiel ME, Kaneko-Tarui T, Kashiwagi A, Pru JK. Sphingosine-1-phosphate receptor expression and signaling correlate with uterine prostaglandin-endoperoxide synthase 2 expression and angiogenesis during early pregnancy. Biol Reprod. 2006;74(3):569–576. Brunnert D, Sztachelska M, Bornkessel F, et al. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells. Mol Hum Reprod. 2014;20(10):1016–1025. Acknowledgments Authors thank Dr Heather M. Martinez for her helpful discussion and critical reading of the manuscript and Ms Maiko Mizuguchi for her excellent technical assistance. Author information Authors and Affiliations Corresponding author Supplemental Material Supplemental Material Supplemental material for this article is available online. Rights and permissions About this article Cite this article Yoshino, O., Yamada-Nomoto, K., Kano, K. et al. Sphingosine I Phosphate (S1P) Increased IL-6 Expression and Cell Growth in Endometriotic Cells. Reprod. Sci. 26, 1460–1467 (2019). https://doi.org/10.1177/1933719119828112 Published: Version of record: Issue date: DOI: https://doi.org/10.1177/1933719119828112